Accelerating policy response to curb non-communicable diseases: an imperative to mitigate the dual public health crises of non-communicable diseases and COVID-19 in India

IF 5 Q1 HEALTH CARE SCIENCES & SERVICES The Lancet regional health. Southeast Asia Pub Date : 2023-03-01 DOI:10.1016/j.lansea.2022.100132
Radhika Shrivastav , Tina Rawal , Ishu Kataria , Ravi Mehrotra , Shalini Bassi , Monika Arora
{"title":"Accelerating policy response to curb non-communicable diseases: an imperative to mitigate the dual public health crises of non-communicable diseases and COVID-19 in India","authors":"Radhika Shrivastav ,&nbsp;Tina Rawal ,&nbsp;Ishu Kataria ,&nbsp;Ravi Mehrotra ,&nbsp;Shalini Bassi ,&nbsp;Monika Arora","doi":"10.1016/j.lansea.2022.100132","DOIUrl":null,"url":null,"abstract":"<div><p>Non-communicable Diseases (NCDs) are a threat to public health and sustainable development. NCDs were equated to being a ‘pandemic’ before COVID-19 originated. Globally, NCDs caused approximately 74% of deaths (2019). India accounted for nearly 14.5% of these deaths. NCDs and COVID-19 have a lethal bi-directional relationship with both exacerbating each other's impact. Health systems and populations, particularly in Low- and Middle-Income Countries (LMICs) like India have among the highest burden of COVID-19. This narrative review tracks key policy and programmatic developments on NCD prevention and control in India, with a focus on commercially-driven risk factors (tobacco and alcohol use, unhealthy diet, physical inactivity, and air pollution), and the corresponding NCD targets. It identifies lacunae and recommends urgent policy-focussed multi-dimensional action, to ameliorate the dual impact of NCDs and COVID-19. India's comprehensive response to NCDs can steer national, regional and global progress towards time-bound NCD targets and NCD-related Sustainable Development Goals (SDGs).</p></div><div><h3>Funding</h3><p>This work is supported by the <span>Commonwealth Foundation</span>. None of the authors were paid to write this article by a pharmaceutical company or other agency. The authors were not precluded from accessing data and accept responsibility to submit for publication.</p></div>","PeriodicalId":75136,"journal":{"name":"The Lancet regional health. Southeast Asia","volume":"10 ","pages":"Article 100132"},"PeriodicalIF":5.0000,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/ee/ba/main.PMC9763206.pdf","citationCount":"5","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Lancet regional health. Southeast Asia","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2772368222001494","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"HEALTH CARE SCIENCES & SERVICES","Score":null,"Total":0}
引用次数: 5

Abstract

Non-communicable Diseases (NCDs) are a threat to public health and sustainable development. NCDs were equated to being a ‘pandemic’ before COVID-19 originated. Globally, NCDs caused approximately 74% of deaths (2019). India accounted for nearly 14.5% of these deaths. NCDs and COVID-19 have a lethal bi-directional relationship with both exacerbating each other's impact. Health systems and populations, particularly in Low- and Middle-Income Countries (LMICs) like India have among the highest burden of COVID-19. This narrative review tracks key policy and programmatic developments on NCD prevention and control in India, with a focus on commercially-driven risk factors (tobacco and alcohol use, unhealthy diet, physical inactivity, and air pollution), and the corresponding NCD targets. It identifies lacunae and recommends urgent policy-focussed multi-dimensional action, to ameliorate the dual impact of NCDs and COVID-19. India's comprehensive response to NCDs can steer national, regional and global progress towards time-bound NCD targets and NCD-related Sustainable Development Goals (SDGs).

Funding

This work is supported by the Commonwealth Foundation. None of the authors were paid to write this article by a pharmaceutical company or other agency. The authors were not precluded from accessing data and accept responsibility to submit for publication.

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
加快遏制非传染性疾病的政策应对:缓解印度非传染性疾病和新冠肺炎双重公共卫生危机的当务之急
非传染性疾病是对公共健康和可持续发展的威胁。在新冠肺炎出现之前,非传染性疾病被视为一种“流行病”。在全球范围内,非传染性疾病造成了约74%的死亡(2019年)。印度占这些死亡人数的近14.5%。非传染性疾病和新冠肺炎具有致命的双向关系,两者都加剧了彼此的影响。卫生系统和人口,特别是印度等中低收入国家的卫生系统和人群,是新冠肺炎负担最高的国家之一。这篇叙述性综述跟踪了印度预防和控制非传染性疾病的关键政策和方案发展,重点关注商业驱动的风险因素(吸烟和饮酒、不健康饮食、缺乏运动和空气污染)以及相应的非传染性疾病目标。它确定了缺陷,并建议采取以政策为重点的多层面紧急行动,以减轻非传染性疾病和新冠肺炎的双重影响。印度对非传染性疾病的全面应对可以引导国家、区域和全球在实现有时限的非传染性疾病目标和与非传染性疾病相关的可持续发展目标方面取得进展。这项工作得到了英联邦基金会的支持。没有一位作者是由制药公司或其他机构付费撰写这篇文章的。作者没有被排除访问数据的权利,并承担提交出版的责任。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
2.20
自引率
0.00%
发文量
0
期刊最新文献
Minimum service standards assessment tool and the hospital strengthening program: a novel first step towards the quality improvement of Nepal’s national hospital system The burden of atrial fibrillation and unmet needs of its management in Southeast Asia and South Asia Community mobilisation and incentivisation as a pathway to sustainable TB control Insights from ESMO Asia Congress 2024 Unveiling the cancer epidemic in India: a glimpse into GLOBOCAN 2022 and past patterns
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1